News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,289 Results
Type
Article (39745)
Company Profile (248)
Press Release (660296)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204192)
Career Advice (2008)
Deals (35424)
Drug Delivery (95)
Drug Development (81053)
Employer Resources (172)
FDA (16189)
Job Trends (14864)
News (345235)
Policy (32548)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49448)
ALS (96)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (133)
Approvals (16187)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (176)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (293)
Cancer (2329)
Cardiovascular disease (180)
Career advice (1677)
Career pathing (30)
CAR-T (159)
Cell therapy (443)
Cervical cancer (20)
Clinical research (66111)
Collaboration (863)
Company closure (2)
Compensation (572)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (252)
Cystic fibrosis (102)
Data (2353)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (277)
Diagnostics (6385)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (98)
Earnings (87165)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112714)
Executive appointments (747)
FDA (17580)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (778)
Gene editing (109)
Generative AI (20)
Gene therapy (320)
GLP-1 (722)
Government (4432)
Grass and pollen (4)
Guidances (169)
Healthcare (18820)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (125)
Indications (29)
Infectious disease (2735)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (312)
IPO (16532)
IRA (40)
Job creations (3633)
Job search strategy (1422)
Kidney cancer (10)
Labor market (43)
Layoffs (475)
Leadership (17)
Legal (7912)
Liver cancer (76)
Lung cancer (326)
Lymphoma (159)
Machine learning (9)
Management (58)
Manufacturing (330)
MASH (79)
Medical device (13389)
Medtech (13394)
Mergers & acquisitions (19476)
Metabolic disorders (714)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (1950)
NextGen: Class of 2025 (6513)
Non-profit (4480)
Now hiring (40)
Obesity (374)
Opinion (205)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (154)
Partnered (22)
Patents (247)
Patient recruitment (116)
Peanut (46)
People (57361)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase I (20604)
Phase II (29122)
Phase III (21676)
Pipeline (1433)
Policy (147)
Postmarket research (2563)
Preclinical (8765)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (386)
Real estate (5907)
Recruiting (65)
Regulatory (22333)
Reports (48)
Research institute (2321)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (134)
Series B (91)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3581)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (51)
The Weekly (30)
Vaccines (699)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (239)
Last 7 days (906)
Last 30 days (3377)
Last 365 days (32493)
2025 (12182)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55711)
2020 (54083)
2019 (46539)
2018 (35018)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37888)
Australia (6195)
California (6500)
Canada (2080)
China (539)
Colorado (277)
Connecticut (283)
Delaware (159)
Europe (81442)
Florida (966)
Georgia (217)
Idaho (57)
Illinois (552)
India (25)
Indiana (323)
Iowa (11)
Japan (174)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (929)
Massachusetts (4824)
Michigan (227)
Minnesota (406)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1805)
New Mexico (28)
New York (1825)
North Carolina (994)
North Dakota (8)
Northern California (2876)
Ohio (211)
Oklahoma (14)
Oregon (34)
Pennsylvania (1438)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (26)
South Dakota (1)
Southern California (2438)
Tennessee (107)
Texas (962)
United States (24269)
Utah (188)
Virginia (153)
Washington D.C. (64)
Washington State (569)
West Virginia (3)
Wisconsin (58)
700,289 Results for "adagene inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
April 29, 2025
·
3 min read
Press Releases
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
April 7, 2025
·
2 min read
Press Releases
Adagene to Present at Leerink’s Global Healthcare Conference 2025
March 6, 2025
·
2 min read
Press Releases
Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
March 25, 2025
·
17 min read
Press Releases
Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit
March 13, 2025
·
4 min read
Biotech Beach
Adagene to Present at Investor Conferences in June
Adagene Inc. today announced its participation in multiple investor conferences in June 2024.
May 22, 2024
·
4 min read
Press Releases
Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
2 min read
Press Releases
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer
February 27, 2025
·
5 min read
Business
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today reported financial results for the full year 2023 and provided corporate updates.
March 29, 2024
·
22 min read
Biotech Beach
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
Adagene Inc. today announced its participation in the Leerink Partners Global Biopharma Conference 2024, taking place March 11-13 in Miami, Florida.
February 27, 2024
·
1 min read
1 of 70,029
Next
